Author avatar

Xu, H. Eric  PhD

Leading researcher with 491 publications in the last 35 years
Dr. H. Eric Xu obtained his bachelor and master degrees in 1985 and 1988, both from Tsinghua University in Beijing, China. He then went to Duke University and the University of Texas Southwestern Medical Center, where he earned his Ph.D. in molecular biology and biochemistry in 1994. Following a postdoctoral fellowship with Dr. Carl Pabo at MIT, he moved to GlaxoWellcome in 1996 as Research Investigator I. He was promoted to Investigator II in 1999 and again to Senior Investigator in 2001. Dr. Xu joined Van Andel Research Institute (VARI) as a Senior Scientific Investigator in 2002, became a Distinguished Investigator/Professor in 2007, and served as the Director of the Center for Structural Biology and Drug Discovery and an executive committee member of VARI in 2010. In July 2010, Dr. Xu established and served as the distinguished Director of the VARI-SIMM Center for Drug Discovery at Shanghai Institute of Materia Medica (SIMM) of Chinese Academy of Sciences. He also serves as the founding Director of the Key Laboratory of Receptor Research of Chinese Academy of Sciences. Research in his group cover structures and drug discovery of nuclear hormone receptors, G-protein coupled receptors, and plant hormones. He has published over 240 papers, with over 29,000 citations. Two of his research papers on plant hormone signaling were selected as top 10 breakthroughs by Science in 2009 and by Chinese Academy of Sciences in 2014. His X-ray laser structure of the first GPCR-arrestin complex was also selected as a top 10 breakthrough by Chinese Academy of Sciences in 2016 and was recognized by the 2016 Hans Neurath Award of Protein Society and the 2016 Wuxi outstanding achievement award. Since September 2019, Dr. Xu returned to SIMM as a Full-Time Professor and a Shanghai Talent-Summit Endowed Professor at SIMM. His research at SIMM has produced three small molecule drugs that have entered clinical trials, including VV116, a nucleoside analog that has been approved for treating COVID-19 after an outstanding efficacy from a Phase 3 clinical trial in Uzbekistan. Dr. Xu was awarded with Tan Jiazhen Life Science Career Achievement Award in 2021 and the Wu Jieping - Paul Janssen Medical & Pharmaceutical Award in 2022. show More

Preview

Evolution over the last 10 years of activity
Aggregated career metrics
491

Total documents

4.36

Normalized Impact

192

Highly Cited Papers (10%)

45.01

International Collab. (%)

Most cited publications


Main coauthors


Following you can review H. Eric's accomplishments in each of the dimensions.

The perfect present for a young Researcher!

Let's do it!
Gift

Dimensions One by One

Spanning 73 diverse indicators, the dimensions considered capture a comprehensive spectrum of academic attributes. Each dimension includes a set of indicators and has a especific weight on the One Index. More information here...

Activity

0
/1000
Reflects an author's research output.

Impact

0
/1000
Reflects an author's academic visibility and the exceptional quality and influence of their most highly cited works.

Excellence

0
/1000
Reflects an author's academic visibility and the exceptional quality and influence of their most highly cited works.

Leadership

0
/1000
Reflects an author's efforts and commitment in leading research initiatives.

Cooperation

0
/1000
Reflects a researcher's ability to navigate and thrive in varied academic and research environments, highlighting adaptability, resourcefulness, and the capacity to build and maintain collaborative relationships across the spectrum of their career.

Openness

0
/1000
Reflects an author's commitment to making their research freely accessible and open to the public.

Community Support

0
/1000
Reflects an author's contributions to the academic community beyond their own research.

Community Recognition

0
/1000
Reflects the academic community's acknowledgment and appreciation of an author's contributions.

Transference

0
/1000
Reflects an author's commitment to making their research a practical application and real-world impact of an author's research.

Fundraising

0
/1000
Reflects an author's ability in securing project funding from major global entities, showcasing your ability to drive research initiatives forward.